Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges

他のバージョン（1件）を表示する

Background: Since the discovery that indoleamine 2,3-dioxygenase (IDO) is a modulator for maintenance of fetomaternal immuno-privilege state, it has been implicated in tumour tolerance, autoimmune diseases and asthma. IDO is an IFN-γ-inducible, intracellular enzyme that catalyzes the initial and rat...

書誌詳細
主要な著者:	Quan, J, Tan, P, MacDonald, A, Friend, P
フォーマット:	Journal article
言語:	English
出版事項:	2008

類似資料

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges.
著者:: Quan, J, 等
出版事項: (2008)

The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
著者:: Chiara Suvieri, 等
出版事項: (2024-11-01)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
著者:: V. A. Kozlov, 等
出版事項: (2017-07-01)

Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
著者:: Cemil Bilir, M.D., 等
出版事項: (2017-07-01)

Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma
著者:: Heike Loeser, 等
出版事項: (2020-01-01)

Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.
著者:: Roberta Mancuso, 等
出版事項: (2015-01-01)

Tolerance induction by monoclonal CD3 antibodies is dependent on indoleamine 2,3 dioxygenase (IDO)
著者:: Kuhn, C, 等
出版事項: (2012)

Inhibition of Indoleamine-2,3-dioxygenase (IDO) in Glioblastoma Cells by Oncolytic Herpes Simplex Virus
著者:: Bonnie Reinhart, 等
出版事項: (2012-01-01)

The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
著者:: Christiane A Opitz, 等
出版事項: (2011-01-01)

Association of Indoleamine 2,3-dioxygenase (ido) activity with outcome after cardiac surgery in adult patients
著者:: Stieger, A, 等
出版事項: (2024)

The role of indoleamine 2,3-dioxygenase (IDO) in the pathogenesis of non-alcoholic steatohepatitis (NASH) and atherosclerosis as comorbidities
著者:: Arora, A, 等
出版事項: (2021)

Association of Indoleamine 2,3-Dioxygenase (IDO) Activity with Outcome after Cardiac Surgery in Adult Patients
著者:: Andrea Stieger, 等
出版事項: (2024-06-01)

Indoleamine 2,3-Dioxygenase (IDO) Activity: A Perspective Biomarker for Laboratory Determination in Tumor Immunotherapy
著者:: Pengbo Yang, 等
出版事項: (2023-07-01)

Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
著者:: Ute F. Röhrig, 等
出版事項: (2022-12-01)

Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG35-55-induced experimental autoimmune encephalomyelitis
著者:: Lisa A. Wetzel, 等
出版事項: (2020-08-01)

Indoleamine 2,3-dioxygenase in endometriosis
著者:: Hui-Li Yang, 等
出版事項: (2019-01-01)

Immunohistochemical Features of Indoleamine 2,3-Dioxygenase (IDO) in Various Types of Lymphoma: A Single Center Experience
著者:: Mee-seon Kim, 等
出版事項: (2020-05-01)

Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma
著者:: Bonanno Giuseppina, 等
出版事項: (2012-12-01)

Indoleamine 2,3-dioxygenase 1 (ido1) is involved in the control of mouse caput epididymis immune environment.
著者:: Aicha Jrad-Lamine, 等
出版事項: (2013-01-01)

Respiratory syncytial virus replication induces Indoleamine 2,3-dioxygenase (IDO) activation in human dendritic cells
著者:: Ajamian Farnam, 等
出版事項: (2010-11-01)

Aging-associated increase in indoleamine 2,3-dioxygenase (IDO) activity appears to be unrelated to the transcription of the IDO1 or IDO2 genes in peripheral blood mononuclear cells
著者:: Jylhä Marja, 等
出版事項: (2011-10-01)

Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers
著者:: Takefumi Komiya, 等
出版事項: (2018-10-01)

Contribution of indoleamine 2,3-dioxygenase in preeclampsia
著者:: Mona F.M El-Karn, 等
出版事項: (2016-01-01)

Increased Indoleamine 2,3-Dioxygenase 1 (IDO-1) Activity and Inflammatory Responses during Chikungunya Virus Infection
著者:: Thiara Manuele Alves de Souza, 等
出版事項: (2022-04-01)

Progesterone decreased indoleamine 2,3-dioxygenase 1(IDO1) expression in early pregnancy chorionic villi and decidua
著者:: Minyan Yang, 等
出版事項: (2021-04-01)

Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO-1) Inhibitors Based on Ortho-Naphthaquinone-Containing Natural Product
著者:: Hongchuan Zhao, 等
出版事項: (2019-03-01)

Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO).
著者:: Juliana Croitoru-Lamoury, 等
出版事項: (2011-01-01)

Synthesis and Molecular Modeling Studies of N′-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
著者:: Dong-Ho Lee, 等
出版事項: (2017-11-01)

Rational design of indoleamine 2,3-dioxygenase inhibitors.
著者:: Röhrig, U, 等
出版事項: (2010)

Inhibitory effect of human indoleamine 2,3-dioxygenase 1 (hIDO1) by kazinols of 1,3-diphenylpropane derivatives
著者:: Taehoon Oh, 等
出版事項: (2024-09-01)

3D-QSAR Study of Indol-2-yl Ethanones Derivatives as Novel Indoleamine 2,3-Dioxygenase (IDO) Inhibitors
著者:: Kamlendra S. Bhadoriya, 等
出版事項: (2012-01-01)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
著者:: Lieve Brochez, 等
出版事項: (2021-12-01)

Activity of Indoleamine 2, 3 Dioxygenase (IDO) in Type 2 Diabetes Mellitus Patients in Pakistan
著者:: Syed Harris Hussain
出版事項: (2017-06-01)

Correction: Inhibitory effect of human indoleamine 2,3-dioxygenase 1 (hIDO1) by kazinols of 1,3-diphenylpropane derivatives
著者:: Taehoon Oh, 等
出版事項: (2024-09-01)

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
著者:: Peng X, 等
出版事項: (2022-08-01)

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
著者:: Aleksandar Acovic, 等
出版事項: (2018-12-01)

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
著者:: Andrew L. Mellor, 等
出版事項: (2017-10-01)

Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer
著者:: Tao Zhang, 等
出版事項: (2017-01-01)

Indoleamine-2,3-dioxygenase (IDO) Mediates the Suppression of T Cells by IFN-γ Primed Mesenchymal Stromal Cells in the Treatment of Psoriasis-Like Inflammation
著者:: Weidong Zhu, 等
出版事項: (2024-12-01)

Systemic treatment with CpG-B after sublethal rickettsial infection induces mouse death through indoleamine 2,3-dioxygenase (IDO).
著者:: Lijun Xin, 等
出版事項: (2012-01-01)